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Revolutionizing the Patient Package Insert with Infographics
Mitchell Cunningham
Abstract: Communication is critical for all aspects of public health. In the pharmaceutical industry, the patient package insert is used to
relay important information to patients. Unfortunately, there are intrinsic flaws with the current patient package insert that can be seen
through the vast number of medical injuries patients incur. This article dissects the root problems of the patient package insert in the
modern world and analyzes the utilization of infographics to combat these issues.
Cunningham M. Revolutionizing the patient package insert with infographics. BU Well. 2016;1:5-6.

I

n a constantly changing world, the only way to thrive is to
adapt to new norms. Adaptation applies to all aspects of society: education, employment, entertainment, public health, and
safety. Despite diminished attention spans being one of the
major changes in today’s world, there is a lack of response in the
public health safety sector. For decades, the U.S. Food and Drug
Administration (FDA) has administered long, detailed Patient
Package Inserts (PPIs) with prescription drugs. These PPIs contain a plethora of crucial information for patients’ safety, including warnings, precautions, adverse reactions, and drug interactions. Additionally, PPIs provide background information about
the drug itself, which can be seen in the clinical studies, description, and clinical pharmacology sections. With people’s diminishing ability to focus their attention, crucial information may be
overlooked or ignored. A revolution in public communication is
pertinent for maintaining safety in the realm of public health.

THE PROBLEM: COMMUNICATION
Not all communication styles are created equal, and
public communication is unique in its topics and target audience. Public communication consists of a group, like the FDA,
communicating with the general public1; PPIs are an example of
this modality. There are a few key characteristics that embody all
public communications: large scale distribution and reception,
heterogeneous audience, impersonal interactions, and an asymmetrical sender-receiver relationship.1 Unfortunately, these
commonalities make public communication difficult. In other
words, public communication is distributed to the masses, who
lack a unifying trait outside of geographical location, eg, the
United States. It is also one-sided since there is no face-to-face
interaction, and the receiver is not able to ask for clarification.
The diverse target-audience makes the word choice challenging
because not all members of the population have the same educational background, yet they must be able to comprehend the
message to the same degree. Furthermore, the asymmetrical
relationship between sender and receiver presents an additional
challenge because impersonal communication makes it more
difficult for the recipient to receive the correct message.
Within pharmacy, public communication can be seen in
a few different areas. Firstly, the FDA can require drug studies of

prescription drugs after they are approved for marketing. The
FDA can also require a risk evaluation and mitigation strategy
(REMS) for potentially dangerous drugs. While REMS may be required in order to gain initial FDA approval, the FDA can also
require REMS to be added to already marketed drugs to help
share important safety discoveries with healthcare professionals.2 Patients may also receive documentation via medication
guides and PPIs based on the additional data gathered when a
drug is widely used.2 Secondly, and perhaps more noticeably,
public communication can be seen with product labelling and
patient package inserts. The pharmaceutical industry has greatly
relied on these two tools to inform patients of health risks since
the 1960s.3
Although the PPI is standard today, it was not unanimously accepted when it was first brought to the public. In the
1970s, the FDA considered requiring the accompaniment of a
PPI with all oral contraceptive pills.4 Both physicians and pharmaceutical companies opposed the idea based on the notion
that it would interfere with the doctor-patient relationship.4 Prior
to 1970s, the physician normally controlled both the patient’s
treatment and how well the patient understood his or her treatment plan.4 This provided physicians with supreme power and
allowed manufacturers and physicians to foster strong relationships with each other.4 Because of the potential lack of understanding by patients, the FDA began requiring PPIs. Charles F.
Keown stated that PPIs would,
promote patient understanding and adherence to drug therapy, permit the patient to
avoid adverse interactions with other drugs or
foods, prepare the patient for possible side
effects, and permit the patient to share in the
decision to use the drug.5
Furthermore, historian Elizabeth Watkins stated that, “in the absence of good doctor-patient communication…, the insert would
supply facts necessary to make an informed choice.”4 These
goals are accurate and desirable, but they are not always easy to
achieve with PPIs alone.
Historically, PPIs have effectively relayed important information about specific drugs. Patient package inserts attempt
to address adverse reactions, both serious and mild, to improve
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safety of the general public. Knowledge of the existence and frequency of adverse drug events is essential in establishing drug
safety.6 One might think PPIs are working beautifully and do not
require tweaking since their major goal coincides with one of the
most import aspects of public health safety. However, PPIs may
not be as effective as desired.
Dr Brian Edwards and Dr Sweta Chakraborty explained
that each individual’s perception influences public reception and
processing of risk communications.3 From this, we can understand that although creators of PPIs have the right goals in mind,
their pamphlets may not convey the proper message to the general public. Moreover, patients are unable to identify the most
crucial of warnings from the PPI. This is evident when observing
that hospital admissions for all medication and drug related
issues have increased by 117% from 1997 to 2008.3 This statistic
is the greatest indication that our patient package inserts are not
adapting to modern times and therefore require modification.
Any modification should address the lack of user-friendliness
and eliminate as much confusion as possible throughout the
entire population. It must ensure that all patient groups can utilize every PPI in order to establish universal drug safety.

result in a lengthy infographic. As the length increases, people’s
declining attention spans will interfere with comprehension.
Therefore, compressing all of the information from a PPI into a
single infographic may result in oversimplification, which would
limit a patient’s understanding of his or her new medicine.
In conclusion, patient package inserts cannot be replaced by infographics, but PPIs should be accompanied by
them. Infographics could drastically help with Black Box Warnings and other sections laden with medical jargon due to their
incorporation of visual aids. Pictographs are a universal
language across populations because they provide multiple inputs to our brain and eliminate many of the barriers of public
communication. Research does not yet exist for the effectiveness
of patient education infographics, but there is potential benefit
of infographics in every patient population.
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